We report development of a method for the direct measurement of the interaction between the N-terminal arm and the remainder of the dimerization domain in the Escherichia coli AraC protein, the regulator of the L-arabinose operon. The interaction was measured using surface plasmon resonance to monitor the association between the immobilized peptide arm and the dimerization domain, truncated of its arm, in solution. As expected from genetic and physiological data, the interaction is strongly stimulated by L-arabinose and is insensitive to sugars like D-glucose or D-galactose. Alterations in the sequence of the arm which physiological experiments predict either to strengthen or weaken the arm produce the expected responses.
In response to the appearance of L-arabinose, the dimeric regulator of the arabinose operon of Escherichia coli, AraC, shifts from binding to two well-separated half-sites on DNA to binding to two adjacent half-sites, where it activates transcription from the p BAD promoter ( Fig. 1) (1, 2) .
Recently, based on genetic, physiological, and structural data, a mechanism has been proposed for the arabinose response of AraC protein (1) (2) (3) (4) (5) . A monomer of the protein can be viewed as consisting of an Nterminal arm comprising about 15 amino acids, the remainder of the dimerization domain that both contains a binding site for arabinose and dimerizes the protein, a linker, and the C-terminal DNA binding domain of the protein. The arms are postulated to shift position in response to arabinose. In the absence of the sugar, the arms are proposed to extend from the dimerization domains where they originate and to bind to the DNA binding domains. The arms plus the interdomain linkers between the dimerization and DNA binding domains of AraC then hold the DNA binding domains in a relative orientation that favors binding of AraC protein to the separated half-sites and formation of a DNA loop. In this state AraC protein not only does not activate transcription from the ara p BAD promoter, but also the protein actively represses promoter activity. When arabinose is present and bound to the dimerization domain, however, the N-terminal arms are believed to bind over the arabinose in the dimerization domain rather than bind to the DNA binding domains. This removal of the arms from the DNA binding domains frees these domains from the orientational constraints provided by the arms and the covalent linkage to the dimerization domains, and the DNA binding domains then bind to two adjacent half-sites on the DNA where they activate transcription. Because the system is on when the arms are in one position, and it is off when they are in the other position, this has been named the "light switch" mechanism (2) .
A variety of genetic and physiological data support the light switch mechanism (1, 2, 6 -8) . As yet, however, no direct physical measurements have shown that the arms bind more tightly to the dimerization domains when arabinose is present. Not only are such data crucial to the model, but the development of direct methods for measurement of the arm-domain interactions in AraC would then permit determination of which residues in the arm participate in the armdimerization domain interactions and which participate in the arm-DNA binding domain interactions. The data resulting from studies with wild-type arms as well as with arms containing variant sequences would both facilitate the engineering of AraC for special responses and provide important data for the engineering of arm-domain interactions onto other proteins. Further, since arm-domain interactions in proteins appear to be relatively common in nature (4, 9 -15), the development of general techniques for their study should prove useful.
Surface plasmon resonance as measured by the BIAcore instrument is an attractive way to measure the peptide-domain interactions (16, 18) believed to be central to the light switch mechanism of AraC. For this measurement technique, one of two interacting molecules is immobilized on a sensor chip, and the second is contained in a solution that flows over the chip. A binding interaction between the two types of molecules can increase the concentration of the second molecule near the immobilization surface. This slightly changes the index of refraction near the surface which is sensitively measured by surface plasmon resonance. The output signal is reported in resonance units, and 1000 resonance units corresponds roughly to 1 ng/mm 2 . Thus, measuring binding with a BIAcore instrument is highly sensitive, and because it can measure association in real time, kinetic as well as equilibrium constants may be determined (19 -23) . Here we report the results of measurements made with surface plasmon resonance that show an arabinose-dependent binding of the arm to the dimerization domain of AraC.
METHODS
Oligonucleotides and peptides. The oligonucleotides that were used in the in vitro mutagenesis to delete codons for amino acids 2-16 of the dimerization domain of AraC were obtained from Integrated DNA Technologies, Inc. (Coralville, IA) as standard purified DNA. They were resuspended in 100 mM Tris-HCl, pH 7.5, and used directly in the Quickchange mutagenesis procedure using standard protocols as described earlier (Stratagene, La Jolla, CA) (24) . Peptides were obtained as lyophilized products from Research Genetics (Huntsville, AL) that were tested by the synthesizing company for purity using mass spectrometry.
Peptide immobilization and surface plasmon resonance. Wild-type peptide was AEAQNDPLLPGYS-FNC, N16D was AEAQNDPLLPGYSFDC, and F15L was AEAQNDPLLPGYSLNC. Peptides were attached to BIAcore carboxymethane dextran-coated CM5 chips. To activate the dextran matrix of a CM5 chip, a mixture of 50 mM N-hydroxy succinimide and 200 mM N-ethyl-NЈ-(dimethyl-aminopropyl)carbodiimide in a total volume of 10 l was injected at a flow rate of 5 l/min into one of the two flow cells on the chip, for a total contact time of 2 min in a BIAcore X machine. This machine can measure surface plasmon resonance simultaneously in two separate areas of a chip. Typically we left one of these areas, called a flow cell, unactivated and activated the surface of the second flow cell. Peptides were immobilized on the second flow cell. Comparison of the surface plasmon resonance signals from the two flow cells provided a measure of the specific binding of the dimerization domain to the immobilized peptide.
To introduce a reactive disulfide group, 80 mM 2-(2-pyridinyldithio)ethane-amine in 100 mM sodium borate, pH 8.5, was injected and allowed to react for 4 min (25) . Following this, peptide containing a C-terminal cysteine was injected at 10 mg/ml in 100 mM sodium formate, pH 4.3, and allowed to remain in contact with the dextran for 7 min. Nonreacted but activated sites were quenched by 50 mM cysteine, 1 M NaCl, in 100 mM sodium formate, pH 4.3, for a contact time of 4 min. Typically, 500 to 1000 response units of peptide were immobilized.
Construction and synthesis of the arm-deleted dimerization domain. High synthesis levels of the dimerization domain of AraC were obtained by placing synthesis of the domain under control of the high-level T7 promoter contained on the T7 expression vector pET 21b (Stratagene). The vector encodes residues 1-182 of AraC, leucine, and glutamic acid residues and six histidine residues followed by a stop codon. DNA corresponding to residues 2-16 was deleted by the Quickchange (Stratagene) protocol using the oligonucleotides GAAGGAGATATACATATGGCCCATCTGG-TGGCG and CGCCACCAGATGGGCCATATGTATAT-CTCCTTC and confirmed by DNA sequencing.
Plasmid coding for the arm-deleted dimerization domain was transformed into BL21DE3 cells (26) . Cells were grown overnight in 10 ml of YT medium (27) FIG. 1. Light switch mechanism for AraC transcription regulation at the arabinose operon p BAD promoter. In the absence of arabinose, AraC prevents transcription at the p BAD promoter by looping between two well-separated half-sites. In the presence of arabinose, the Nterminal arms of AraC fold over the arabinose binding pocket in the dimerization domain of the protein, release the DNA binding domains, and allow them to bind to adjacent DNA half-sites. When AraC is bound in this way, it activates transcription from p BAD .
containing 10 g/ml ampicillin and diluted to 1 liter in the same. After 2 h, isopropyl ␤-D-thiogalactoside was added at a final concentration of 1 mM to induce high synthesis rates of the T7 RNA polymerase that in turn induces high rates of synthesis of the AraC dimerization domain. The cells were grown at 37°C for an additional 3 h, harvested, and frozen. Approximately 4.5 g of cells was ground with 2.5 weights levigated alumina. Then 10 ml of 15 mM Tris-HCl, pH 8.0, 100 mM NaCl, 10 mM ␤-mercaptoethanol, 0.5 mM freshly dissolved phenylmethylsulfonyl fluoride, 10 mM imidazole, and 5% glycerol was added. DNase to 50 g/ml and RNase A to 50 g/ml were added and the mixture was incubated at 4°C for 15 min before centrifugation at 6000g for 10 min.
The supernatant from the centrifugation was added to 8 ml Ni-NTA resin, obtained from Qiagen (Valencia, CA), that had been washed once with 50 ml deionized water and twice with washing buffer (15 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 10 mM ␤-mercaptoethanol, 10 mM imidazole, 5% glycerol). After rocking gently overnight at 4°C, the beads were rinsed five times with wash buffer, and the dimerization domain was eluted with two rinses of elution buffer in which the imidazole was increased to 1 M and two rinses in which imidazole was at 500 mM. The fractions containing the most pure dimerization domain were determined by SDS-gel electrophoresis on a 14% gel. We found it necessary to remove contaminants or aggregated protein by ammonium sulfate precipitation. A volume of 20 ml of eluate from the nickel beads was brought to 25% of saturation in ammonium sulfate (assuming saturation requires the addition of 70.5 g ammonium sulfate per 100 ml) by the addition of solid ammonium sulfate over a 15-min interval. This was stirred overnight at 4°C and the protein was pelleted by centrifugation at 10,000g for 20 min. The dimerization domain was resuspended in 5 ml 15 mM Tris-HCl, pH 7.5, 75 mM KCl, 13 mM L-arabinose. The OD 260 /OD 280 ratio of the protein was 0.5 to 0.66. Before experiments, a volume of protein was dialyzed into the appropriate buffer for at least 90 min, a time sufficient for buffer equilibration.
Biomolecular interaction measurements on BIAcore X (18, 20 -23) . All interaction analysis assays were conducted at 25°C with a flow rate of 5 l/min. Typically, a contact time of 3 min was allowed for association and 7 min for dissociation. Binding was taken as the difference between the signals from the flow cell containing immobilized peptide and a flow cell run in series that did not contain immobilized peptide. The nondissociating interaction component that we observed was removed with a 30-to 60-s pulse of 100 mM HCl. In the experiments assaying sugar dependence of binding, the dimerization domain was dialyzed into 15 mM Tris-HCl, pH 7.5, 75 mM KCl containing sugar. The same buffer was used as the protein-free buffer. Chips with immobilized peptide were wrapped in moist paper towels and stored at 4°C in sealed tubes.
RESULTS
The N-terminal arm-dimerization domain interaction in AraC that we wished to study is intermolecular. It was possible, however, to separate the arm from the remainder of the dimerization domain by engineering the synthesis of the dimerization domain lacking the arm. The arm was provided separately as a peptide that was immobilized on the surface of the chip. Interaction between the arm-deleted peptide and the peptide was then monitored with surface plasmon resonance while flowing buffer containing the arm-deleted dimerization domain across the chip. Based on the in vivo stability and activity of N-truncated AraC protein molecules (28), we chose to delete the first 15 amino acids of the dimerization domain, and to facilitate its purification, we added six C-terminal histidine residues (16) . In the experiments reported here, we used chemically synthesized peptides that included residues 2-15 of the N-terminal arm that were followed by a cysteine. This permitted thiol-based linkage of the peptide to the dextran matrix on the plasmon resonance chip. Figure 2 shows typical binding results. The association began as soon as buffer containing dimerization domain began to flow across the chip. Dissociation began when buffer lacking dimerization domain began to flow across the chip. The binding appeared to contain two components. One component showed typical exponential dissociation kinetics, and the other appeared to be stable on the time scale of these experiments. This nondissociating bound component was removed between experiments with 0.1 M HCl. In most of the experiments described here, the amounts of dissociable and nondissociable binding were about equal. As is required if the assay truly is measuring binding between the dimerization domain and the immobilized peptide, the amount of bound material increased as the concentration of dimerization domain in the flow buffer increased. One indication that the peptide-dimerization domain interactions observed were specific was the fact that substituting bovine serum albumin for dimerization showed no binding (data not shown).
A more stringent test of the significance of the interactions we observed in the first experiment was to test the sugar dependence of the associations. AraC protein responds to L-arabinose, but not to most other sugars, including D-glucose and D-galactose. D-Fucose, a structural analog of L-arabinose, inhibits induction by arabinose (29) , but since it binds to AraC in the arabinose pocket (5), it may somewhat stimulate binding of the arm to the dimerization domain. The arm-domain interactions we observed (Fig. 3) paralleled these expectations. The binding was arabinose dependent. Glucose and galactose induced almost no binding and fucose induced an intermediate amount of binding. Figure 4 shows that as the arabinose concentration was increased, the amount of binding increased.
Mutations in the dimerization domain or in the arm that affect the strength of the arm-domain interaction ought to change the binding we observe. Two candidate mutations are known for such studies. A change of asparagine 16 to aspartic acid, abbreviated N16D, changes AraC protein so that it no longer needs arabinose for it to activate transcription. According to the light switch mechanism, the arm in this mutant would be held to the dimerization domain even in the absence of arabinose. Such a tighter binding of the arm is certainly plausible. When the arm is bound to the dimerization domain, the N16D mutation places the negatively charged aspartic acid within 5 Å of two positive charges on the dimerization domain, K43 and R99 (7). The mutation F15L has the opposite behavior (1). That is, it does not respond to arabinose. As F15 makes a van der Waals interaction with arabinose, its change to leucine may weaken this interaction and the arm thus fails to bind to the dimerization domain. We checked these two predictions by immobilizing peptides containing the N16D and F15L alterations (Fig.  5) . With immobilized N16D peptide, the amount of the nondissociating component to the binding signal was consistently higher than that seen with wild-type peptide-containing chips. Conversely, chips containing the F15L peptide bound very little of the dimerization domain. Both results were as expected if the light switch model is correct and if the binding experiments work as expected. 
DISCUSSION
In the absence of arabinose, the N-terminal 15 amino acids of the AraC protein, the regulator of the arabinose operon of E. coli, appear to bind to the C-terminal domain of AraC, a DNA binding domain (2) . In the presence of arabinose, the arm instead appears to bind to the N-terminal dimerization domain of AraC (1, 2) . When the arm is in one position, the protein represses the arabinose operon, and when it is in the other position, AraC activates transcription of the arabinose operon. Structural, genetic, and physiological data support this light switch role for the arm of AraC. Here we have described experiments that directly demonstrate the hypothesized behavior of the N-terminal arm of AraC. Peptide corresponding to the arm was immobilized on chips, and the binding of AraC truncated of its DNA binding domain and of its N-terminal arm (leaving only the dimerization domain) to the peptide was measured in real time with surface plasmon resonance measurements on a BIAcore X instrument.
Binding of the dimerization domain showed the same sugar specificity as induction of the arabinose operon (1) (2) (3) 5) . That is, binding required arabinose and showed a slight response to the arabinose analog D-fucose, which also binds to AraC (29) , but showed no significant response to glucose or galactose (3) . In all of the experiments, about half of the binding appeared to be reversible with a dissociation half time of about 1 min and half appeared to be irreversible. We do not understand the origin or meaning of the nondissociable component. The binding also responded to changes in the amino acid sequence of the immobilized peptide as predicted for the behavior of mutants carrying the corresponding mutations. A peptide corresponding to a mutant that is constitutive by virtue of a mutation that likely increases the tightness of the arm-dimerization domain interaction, N16D, bound more tightly than peptide carrying the wild-type sequence. Conversely, peptide carrying a mutation predicted not to respond to arabinose, F15L, in fact did not show an arabinose response.
Binding of the truncated dimerization domain to the immobilized peptide arms reproducibly showed a response at arabinose concentrations on the order of 0.02 mM and lower. It is possible that interactions with the dextran backbone contributed to this unexpectedly sensitive response, for by fluorescence measurements we found that the arm-truncated dimerization domain in solution in the presence or absence of an excess of the arm appeared to bind arabinose with a K d of about 0.1 to 0.2 mM (data not shown).
The measurements presented here are the first physical measurements of the arm-dimerization domain interactions in AraC protein. These results do not constitute a rigorous proof of the light switch mechanism. Rather, the correlation between these measurements and predictions based on the mechanism increases the likelihood of the correctness of the mechanism. Altogether, however, the variety of data now known in support of the light switch mechanism is quite large and the mechanism seems highly likely to be essentially correct. That being the case, the surface plasmon resonance measurements described here provide a tool for deeper analysis of the mechanism.
